Delaney Lia D, Furst Adam, Day Heather, Arnow Katherine, Cisco Robin M, Kebebew Electron, Montez-Rath Maria E, Tamura Manjula Kurella, Seib Carolyn D
Stanford-Surgery Policy Improvement Research and Education Center (S-SPIRE), Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
JAMA Surg. 2024 Dec 1;159(12):1375-1382. doi: 10.1001/jamasurg.2024.3509.
Primary hyperparathyroidism (PHPT) is a common endocrine disorder associated with neuropsychiatric symptoms. Although parathyroidectomy has been associated with improvement of preexisting depression among adults with PHPT, the effect of parathyroidectomy on the development of new depression is unknown.
To determine the effect of early parathyroidectomy on the incidence of new depression among adults with PHPT compared with nonoperative management.
DESIGN, SETTING, AND PARTICIPANTS: Analyzed data included observational national Veterans Affairs data from adults with a new diagnosis of PHPT from 2000 through 2019 using target trial emulation with cloning, a biostatistical method that uses observational data to emulate a randomized clinical trial. New depression rates were compared between those treated with early parathyroidectomy vs nonoperative management using an extended Cox model with time-varying inverse probability censoring weighting, adjusted for patient demographics, comorbidities, and depression risk factors. Eligible adults with a new biochemical diagnosis of PHPT, excluding those with past depression diagnoses, residing in an assisted living/nursing facility, or with Charlson Comorbidity Index score higher than 4 were included. These data were analyzed January 4, 2023, through June 15, 2023.
Early parathyroidectomy (within 1 year of PHPT diagnosis) vs nonoperative management.
New depression, including among subgroups according to patient age (65 years or older; younger than 65 years) and baseline serum calcium (11.3 mg/dL or higher; less than 11.3 mg/dL).
The study team identified 40 231 adults with PHPT and no history of depression of whom 35896 were male (89%) and the mean (SD) age was 67 (11.3) years. A total of 3294 patients underwent early parathyroidectomy (8.2%). The weighted cumulative incidence of depression was 11% at 5 years and 18% at 10 years among patients who underwent parathyroidectomy, compared with 9% and 18%, respectively, among nonoperative patients. Those treated with early parathyroidectomy experienced no difference in the adjusted rate of new depression compared with nonoperative management (hazard ratio, 1.05; 95% CI, 0.94-1.17). There was also no estimated effect of early parathyroidectomy on new depression in subgroup analyses based on patient age or serum calcium.
In this study, there was no difference in the incidence of new depression among adults with PHPT treated with early parathyroidectomy vs nonoperative management, which is relevant to preoperative discussions about the benefits and risks of operative treatment.
原发性甲状旁腺功能亢进症(PHPT)是一种与神经精神症状相关的常见内分泌疾病。虽然甲状旁腺切除术与改善成年PHPT患者先前存在的抑郁症有关,但甲状旁腺切除术对新发抑郁症的影响尚不清楚。
确定与非手术治疗相比,早期甲状旁腺切除术对成年PHPT患者新发抑郁症发生率的影响。
设计、设置和参与者:分析的数据包括2000年至2019年新诊断为PHPT的成年退伍军人事务部全国观察性数据,采用克隆的目标试验模拟法,这是一种利用观察性数据模拟随机临床试验的生物统计学方法。使用扩展的Cox模型与时变逆概率删失加权法比较早期甲状旁腺切除术与非手术治疗患者的新发抑郁症发生率,并对患者人口统计学、合并症以及抑郁症风险因素进行调整分析研究。纳入符合条件的新诊断为PHPT的成年患者,排除既往有抑郁症诊断、居住在辅助生活/护理机构或Charlson合并症指数得分高于4的患者。这些数据于2023年1月4日至2023年6月15日进行分析。
早期甲状旁腺切除术(PHPT诊断后1年内)与非手术治疗。
新发抑郁症,包括根据患者年龄(65岁及以上;65岁以下)和基线血清钙水平(11.3mg/dL及以上;低于11.3mg/dL)进行亚组分析。
研究团队确定了40231例无抑郁症病史的PHPT成年患者,其中35896例为男性(89%),平均(标准差)年龄为67(11.3)岁。共有3294例患者接受了早期甲状旁腺切除术(8.2%)。接受甲状旁腺切除术的患者5年时抑郁症加权累积发生率为11%,10年时为18%,而非手术治疗患者分别为9%和18%。与非手术治疗相比,接受早期甲状旁腺切除术的患者新发抑郁症调整率无差异(风险比,1.05;95%CI,0.94-1.17)。在基于患者年龄或血清钙的亚组分析中,早期甲状旁腺切除术对新发抑郁症也没有估计影响。
在本研究中,早期甲状旁腺切除术与非手术治疗的成年PHPT患者新发抑郁症发生率无差异,这与术前关于手术治疗利弊讨论相关。